• Exchange: NASDAQ CM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Northwest Biotherapeutics Inc

+ Add to Watchlist

NWBO:US

6.0700 USD 0.1200 2.02%

As of 17:20:00 ET on 07/22/2014.

Company Profile for Northwest Biotherapeutics Inc (NWBO)

Northwest Biotherapeutics, Inc., a biotechnology company, discovers, develops, and commercializes immunotherapy products. The Company's products generate and enhance immune system responses to treat cancer. The DCVax product candidate platform creates cancer immunotherapies.

Contact Information

Northwest Biotherapeutics Inc

4800 Montgomery Lane
Suite 800
Bethesda, MD 20814
United States
Phone: 1-240-497-9024

Key Executives for Northwest Biotherapeutics Inc (NWBO)

Linda F PowersChairman/President/CEOMarnix L BoschChief Technology Officer
Alton L BoyntonChief Scientific OfficerAnthony E Maida IIISenior VP:Clinical Research
Leslie J GoldmanSenior VP:Business Dev

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil